Halozyme Therapeutics Inc (HALO)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	1,499,250	1,497,620	1,496,000	1,494,380	1,492,770	1,491,160	—	—	787,255	—	—	—	0	—	—	—	383,045	—	—	—
Total assets	US$ in thousands	1,733,270	1,892,660	1,810,440	1,699,450	1,841,510	1,864,540	1,781,390	1,162,250	1,104,430	1,185,420	1,025,860	966,582	579,924	524,029	526,997	492,353	565,874	370,356	417,830	429,109
Debt-to-assets ratio		0.86	0.79	0.83	0.88	0.81	0.80	0.00	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,499,250K ÷ $1,733,270K
= 0.86

The debt-to-assets ratio of Halozyme Therapeutics Inc. has exhibited some fluctuations over the past eight quarters. The ratio has ranged from 0.70 to 0.88 during this period. In Q4 2023, the ratio stands at 0.86, indicating that for every dollar of assets, the company has $0.86 in debt.

The trend in the debt-to-assets ratio shows that there has been some variability in the level of debt relative to total assets. While the ratio peaked in Q1 2023 at 0.88, it decreased slightly in the following quarters, reaching a low of 0.70 in Q2 2022 before trending upwards again.

A higher debt-to-assets ratio suggests that the company relies more on debt financing to fund its operations and investments, which can indicate higher financial risk. Conversely, a lower ratio may imply a stronger financial position with less reliance on debt.

Overall, a close monitoring of the debt-to-assets ratio, along with other financial metrics, is essential for understanding Halozyme Therapeutics Inc.'s capital structure and financial health. The company's management should assess the appropriateness of its debt levels in relation to its assets and overall business strategy.